Stent thrombosis: A clinical perspective

JACC: Cardiovascular Interventions

Volumn 7, Issue 10, 2014, Pages 1081-1092

  Claessen, Bimmer E ^a   Henriques, José P S ^a   Jaffer, Farouc A ^b   Mehran, Roxana ^c,d   Piek, Jan J ^a   Dangas, George D ^c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

coronary artery disease; percutaneous coronary intervention; stent thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CLOPIDOGREL; PRASUGREL; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; CARDIOVASCULAR MORTALITY; CORONARY STENT; HUMAN; INTRAVASCULAR ULTRASOUND; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; RISK ASSESSMENT; STENT EDGE DISSECTION; STENT FRACTURE; STENT MALAPPOSITION; STENT THROMBOSIS; STENT UNDEREXPANSION; THROMBOCYTE ACTIVATION; TREATMENT DURATION; TREATMENT OUTCOME; ADVERSE EFFECTS; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DEVICES; DIAGNOSTIC IMAGING; DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSTHESIS; RISK FACTOR; STENT; TIME;

CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DIAGNOSTIC IMAGING; DRUG ADMINISTRATION SCHEDULE; FIBRINOLYTIC AGENTS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908179649     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.05.016     Document Type: Review

References (87)

1. K. Detre, R. Holubkov, and S. Kelsey One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry Circulation 80 1989 421 428
2. D.L. Fischman, M.B. Leon, and D.S. Baim A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators N Engl J Med 331 1994 496 501
3. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
4. P.J. de Feyter, I. DeScheerder, B.M. van den, G. Laarman, H. Suryapranata, and P.W. Serruys Emergency stenting for refractory acute coronary artery occlusion during coronary angioplasty Am J Cardiol 66 1990 1147 1150
5. P.W. Serruys, B.H. Strauss, and K.J. Beatt Angiographic follow-up after placement of a self-expanding coronary-artery stent N Engl J Med 324 1991 13 17
6. U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, and L. Kappenberger Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty N Engl J Med 316 1987 701 706
7. P.W. Serruys, J.P. de, and F. Kiemeneij A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group N Engl J Med 331 1994 489 495
8. A. Colombo, P. Hall, and S. Nakamura Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance Circulation 91 1995 1676 1688
9. M.B. Leon, D.S. Baim, and J.J. Popma A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators N Engl J Med 339 1998 1665 1671
10. A. Schomig, F.J. Neumann, and A. Kastrati A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089
11. E. Kedhi, K.S. Joesoef, and E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
12. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
13. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
14. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
15. E.P. McFadden, E. Stabile, and E. Regar Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
16. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
17. B. Doyle, C.S. Rihal, and C.J. O'Sullivan Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents Circulation 116 2007 2391 2398
18. J.Y. Moon, M.H. Jeong, and I.S. Kim Long-term clinical outcome and prognosis after treatment of the first generation drug-eluting stent thrombosis Int J Cardiol 145 2010 564 566
19. J.W. van Werkum, A.A. Heestermans, and A.C. Zomer Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry J Am Coll Cardiol 53 2009 1399 1409
20. P. Wenaweser, C. Rey, and F.R. Eberli Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome Eur Heart J 26 2005 1180 1187
21. T. Kimura, T. Morimoto, and K. Kozuma Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) Circulation 122 2010 52 61
22. F. Alfonso, A. Suarez, and D.J. Angiolillo Findings of intravascular ultrasound during acute stent thrombosis Heart 90 2004 1455 1459
23. T. Kubo, T. Imanishi, and S. Takarada Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy J Am Coll Cardiol 50 2007 933 939
24. M. Ergelen, S. Gorgulu, and H. Uyarel The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction Am Heart J 159 2010 672 676
25. J.M. Lasala, D.A. Cox, and D. Dobies Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries Circ Cardiovasc Interv 2 2009 285 293
26. T. Chechi, S. Vecchio, and G. Vittori ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients J Am Coll Cardiol 51 2008 2396 2402
27. A.T. Ong, A. Hoye, and J. Aoki Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation J Am Coll Cardiol 45 2005 947 953
28. P.K. Kuchulakanti, W.W. Chu, and R. Torguson Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents Circulation 113 2006 1108 1113
29. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
30. D.E. Cutlip, D.S. Baim, and K.K. Ho Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
31. T. Kimura, T. Morimoto, and Y. Nakagawa Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation 119 2009 987 995
32. J.M. de la Torre-Hernandez, F. Alfonso, and F. Hernandez Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos) J Am Coll Cardiol 51 2008 986 990
33. J. Aoki, A.J. Lansky, and R. Mehran Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 119 2009 687 698
34. G.D. Dangas, B.E. Claessen, and R. Mehran Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 59 2012 1752 1759
35. G.D. Dangas, A. Caixeta, and R. Mehran Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction Circulation 123 2011 1745 1756
36. F. D'Ascenzo, M. Bollati, and F. Clementi Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses Int J Cardiol 167 2013 575 584
37. E. Cheneau, L. Leborgne, and G.S. Mintz Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study Circulation 108 2003 43 47
38. I. Moussa, M.C. Di, B. Reimers, T. Akiyama, J. Tobis, and A. Colombo Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome J Am Coll Cardiol 29 1997 6 12
39. P.G. Steg, A. van't Hof, and C.W. Hamm Bivalirudin started during emergency transport for primary PCI N Engl J Med 369 2013 2207 2217
40. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
41. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
42. S. Cook, P. Wenaweser, and M. Togni Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434
43. C.W. Lee, S.J. Kang, and D.W. Park Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation J Am Coll Cardiol 55 2010 1936 1942
44. K. Hasegawa, H. Tamai, and E. Kyo Histopathological findings of new in-stent lesions developed beyond five years Catheter Cardiovasc Interv 68 2006 554 558
45. G. Nakazawa, M. Vorpahl, A.V. Finn, J. Narula, and R. Virmani One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis J Am Coll Cardiol Img 2 2009 625 628
46. F. Otsuka, M. Vorpahl, and M. Nakano Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans Circulation 120 2014 211 223
47. M. Taniuchi, H.I. Kurz, and J.M. Lasala Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population Circulation 104 2001 539 543
48. C. Muller, H.J. Buttner, J. Petersen, and H. Roskamm A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents Circulation 101 2000 590 593
49. M.E. Bertrand, H.J. Rupprecht, P. Urban, and A.H. Gershlick Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) Circulation 102 2000 624 629
50. H. Caplain, F. Donat, C. Gaud, and J. Necciari Pharmacokinetics of clopidogrel Semin Thromb Hemost 25 Suppl 2 1999 25 28
51. G.W. Stone, B. Witzenbichler, and G. Weisz Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Lancet 382 2013 614 623
52. J.T. Brandt, C.D. Payne, and S.D. Wiviott A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J 153 2007 66e.9-16
53. D.L. Bhatt, G.W. Stone, and K.W. Mahaffey Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med 368 2013 1303 1313
54. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
55. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
56. S.R. Mehta, J.F. Tanguay, and J.W. Eikelboom Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
57. R.A. Harrington, G.W. Stone, and S. McNulty Platelet inhibition with cangrelor in patients undergoing PCI N Engl J Med 361 2009 2318 2329
58. S.D. Wiviott, E. Braunwald, and D.J. Angiolillo Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38 Circulation 118 2008 1626 1636
59. G. Montalescot, S.D. Wiviott, and E. Braunwald Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
60. W.J. Dewilde, T. Oirbans, and F.W. Verheugt Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
61. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
62. S. Windecker, P. Kohl, and F. Alfonso 2014 ESC/EACTS guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and the European Association for cardio-thoracic surgery (EACTS) developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI) Eur Heart J 2014 Aug 29 [E-pub ahead of print]
63. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
64. B.K. Kim, M.K. Hong, and D.H. Shin A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) J Am Coll Cardiol 60 2012 1340 1348
65. F. Feres, R.A. Costa, and A. Abizaid Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial JAMA 310 2013 2510 2522
66. M. Valgimigli, G. Campo, and M. Monti Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
67. S.J. Park, D.W. Park, and Y.H. Kim Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
68. G. Dangas, E.D. Aymong, and R. Mehran Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial) Am J Cardiol 94 2004 983 988
69. R. Mehran, A.J. Lansky, and B. Witzenbichler Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
70. Y. Kobayashi, P. Teirstein, T. Linnemeier, G. Stone, M. Leon, and J. Moses Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque Catheter Cardiovasc Interv 52 2001 208 211
71. A. Latib, K. Takagi, and G. Chizzola Excimer Laser LEsion modification to expand non-dilatable stents: the ELLEMENT registry Cardiovasc Revasc Med 15 2014 8 12
72. G.G. Biondi-Zoccai, P. Agostoni, and G.M. Sangiorgi Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation Eur Heart J 27 2006 540 546
73. T. Canan, and M.S. Lee Drug-eluting stent fracture: incidence, contributing factors, and clinical implications Catheter Cardiovasc Interv 75 2010 237 245
74. K. Yamaji, K. Inoue, and T. Nakahashi Bare metal stent thrombosis and in-stent neoatherosclerosis Circ Cardiovasc Interv 5 2012 47 54
75. S.J. Kang, G.S. Mintz, and T. Akasaka Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation Circulation 123 2011 2954 2963
76. G.G. Stefanini, M. Taniwaki, and S. Windecker Coronary stents: novel developments Heart 100 2014 1051 1061
77. T. Palmerini, G. Biondi-Zoccai, and D.D. Riva Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
78. S. Bangalore, B. Toklu, and N. Amoroso Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis BMJ 347 2013 f6625
79. E.P. Navarese, K. Tandjung, and B. Claessen Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis BMJ 347 2013 f6530
80. G.D. Dangas, B.E. Claessen, and R. Mehran Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes J Am Coll Cardiol Intv 5 2012 1097 1105
81. P. Roy, D.H. Steinberg, and S.J. Sushinsky The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents Eur Heart J 29 2008 1851 1857
82. A. Hoye, I. Iakovou, and L. Ge Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome J Am Coll Cardiol 47 2006 1949 1958
83. T.K. Steigen, M. Maeng, and R. Wiseth Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study Circulation 114 2006 1955 1961
84. J.A. Spertus, R. Kettelkamp, and C. Vance Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809
85. G.D. Dangas, B.E. Claessen, R. Mehran, K. Xu, and G.W. Stone Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial EuroIntervention 8 2013 1033 1039
86. R. Mehran, U. Baber, and P.G. Steg Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study Lancet 382 2013 1714 1722
87. E.J. Armstrong, D.N. Feldman, and T.Y. Wang Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis J Am Coll Cardiol Intv 5 2012 131 140